Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Willie Earley |
Documentos disponibles escritos por este autor (2)
Refinar búsquedaCariprazine treatment of bipolar depression / Willie Earley en The American Journal of Psychiatry, Año 2019 - Vol. 176 - No. 6 (Junio)
Título : Cariprazine treatment of bipolar depression : A randomized double-blind placebo-controlled phase 3 study Tipo de documento: texto impreso Autores: Willie Earley, Autor ; Maria Victoria Burgess, Autor ; Ludmyla Rekeda, Autor Fecha de publicación: 2019 Artículo en la página: pp. 439-448 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno bipolar I, Depresión bipolar, Cariprazina, Antipsicótico atípico, Ensayo controlado aleatorizado. Resumen: Cariprazine, a dopamine D3/D2 and 5-HT1A receptor partial agonist, was found to be effective in treating bipolar I depression in a previous phase 2 study. This phase 3 study further assessed the efficacy, safety, and tolerability of cariprazine in bipolar I depression. Link: ./index.php?lvl=notice_display&id=20717
in The American Journal of Psychiatry > Año 2019 - Vol. 176 - No. 6 (Junio) . - pp. 439-448[artículo] Cariprazine treatment of bipolar depression : A randomized double-blind placebo-controlled phase 3 study [texto impreso] / Willie Earley, Autor ; Maria Victoria Burgess, Autor ; Ludmyla Rekeda, Autor . - 2019 . - pp. 439-448.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2019 - Vol. 176 - No. 6 (Junio) . - pp. 439-448
Palabras clave: Trastorno bipolar I, Depresión bipolar, Cariprazina, Antipsicótico atípico, Ensayo controlado aleatorizado. Resumen: Cariprazine, a dopamine D3/D2 and 5-HT1A receptor partial agonist, was found to be effective in treating bipolar I depression in a previous phase 2 study. This phase 3 study further assessed the efficacy, safety, and tolerability of cariprazine in bipolar I depression. Link: ./index.php?lvl=notice_display&id=20717
Título : Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants : A randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder Tipo de documento: texto impreso Autores: Suresh Durgam, Autor ; Willie Earley, Autor ; Hua Guo, Autor Fecha de publicación: 2020 Artículo en la página: pp. 371–378 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo mayor - terapia farmacológica, Resistencia a los medicamentos, Terapia farmacológica, Piperazinas - efectos adversos. Resumen: Cariprazine is an atypical antipsychotic currently under investigation as adjunctive therapy in patients with major depressive disorder (MDD) who have inadequate response to standard antidepressant therapy. Link: ./index.php?lvl=notice_display&id=21716
in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.3 (Marzo) . - pp. 371–378[artículo] Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants : A randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder [texto impreso] / Suresh Durgam, Autor ; Willie Earley, Autor ; Hua Guo, Autor . - 2020 . - pp. 371–378.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.3 (Marzo) . - pp. 371–378
Palabras clave: Antidepresivos, Trastorno depresivo mayor - terapia farmacológica, Resistencia a los medicamentos, Terapia farmacológica, Piperazinas - efectos adversos. Resumen: Cariprazine is an atypical antipsychotic currently under investigation as adjunctive therapy in patients with major depressive disorder (MDD) who have inadequate response to standard antidepressant therapy. Link: ./index.php?lvl=notice_display&id=21716
